The new Board of Directors recently announced the allocation of funds for pharmacovigilance amounting to approximately 5 million euros.

AIFA’s new Board of Directors

The recent AIFA reform introduced a new Board of Directors. The Board took office on March 20, 2024, as announced by AIFA, and consists of:

  • Francesco Fera, Vice President and Counselor appointed by the Minister of Health;
  • Emanuele Monti, Counselor appointed by the Minister of Economy and Finance;
  • Angelo Gratarola, Counselor appointed by the Permanent Conference for Relations between the State, the Regions, and the Autonomous Provinces of Trento and Bolzano;
  • Vito Montanaro, Counselor appointed by the Permanent Conference for Relations between the State, the Regions, and the Autonomous Provinces of Trento and Bolzano.

Commitment to pharmacovigilance

During the recent inauguration of AIFA’s new Board of Directors, it was announced, in agreement with the Regions, the commitment to finance projects on pharmacovigilance amounting to €5,051,397, along with the allocation of PNRR Funds for interventions to enhance corporate cybersecurity totalling €480,000.

The announcement of the investment in pharmacovigilance projects demonstrates the Agency’s commitment to drug safety and surveillance processes.